1st Edition

Atypical Antipsychotics From Bench to Bedside

Edited By John C. Csernansky, John Lauriello Copyright 2004

    Showcasing the latest studies in the field, this reference unveils recent breakthroughs in the use of atypical antipsychotics for the treatment of a variety of patient populations-tracking developments in the management of patients with schizophrenia and affective psychotic disorders, as well as therapeutic regimens for children and adolescents.

    Atypical Antipsychotic Drugs: Theories of Mechanism of Action Scott Filippino and John G. Csernansky; Probing the Receptorsome Unveils the Receptor Pharmacology of Atypical Antipsychotic Drugs Bryan L. Roth; Neurophysiological Effects of Atypical Antipsychotic Drugs Patricio O'Donnell; Behavioral Models of Atypical Antipsychotic Drug Action in Rodents Mark E. Bardgett; Metabolic Regulation and Atypical Antipsychotic Drugs Pierre Chue; The Nosology of Psychosis: Schizophrenia, Affective Psychotic Disorders, and Drug-Induced Psychotic Disorders John Lauriello; Acute Efficacy of Atypical Antipsychotic Drugs Steve Marder; Long-Term Efficacy of Atypical Antipsychotic Drugs Robert Conley; Assessing the Effects of Atypical Antipsychotics on the CNS Utilizing Neuroimaging Juan Bustillo; Use of Atypical Antipsychotic Drugs in Children and Adolescents Peter Buckley; Use of Atypical Antipsychotic Drugs for the Treatment of Affective Disorders Martha Sajatovic; New Approaches to Drug Development Donald C. Goff; Index

    Biography

    John C. Csernansky, Washington University School of Medicine, St Louis Missouri. John Lauriello, University of New Mexico, Albuquerque.

    "provide[s] current useful and intelligent reviews."
    -American Journal of Psychiatry